Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2017: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2015: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
|
Outline of Final Research Achievements |
As a new control structure of B cell lymphoma, B-cell activated control by serum protein MD-1 was suggested. Because MD-1 is a lipid binding molecule and it also associates with RP105 inducing B-cell activation, lipid combination and the connection with the B-cell activation are thought about. Further analysis is necessary how the B cell lymphoma tendency is gained in the MD-1 deleted SLE model mouse by the B-cell activation reinforcement through Lipid and the receptor.
|